This brand name is authorized in Nigeria. It is also authorized in Hong Kong SAR China.
The drug ROFENAC contains one active pharmaceutical ingredient (API):
1
|
UNII
QTG126297Q - DICLOFENAC SODIUM
|
|
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-3272 | Gel | ROFENAC GEL GEL 1% 1 X 30G | 31 RNW-PP-100955 ROFENAC GEL DICLOFENAC SODIUM DICLOFENAC SODIUM 1%W/W B4-3272 Drugs NERVOUS SYSTEM Nigerian Products 130G Prescription Only Medicine (POM) 9/28/2019 REAGAN REMEDIES LIMITED, UMARU MUSA YARA'DUA DRIVE, OWERRI OWERRI IMO 8032223520 reganremedies@gmail.com REAGAN REMEDIES LIMITED, 24 UMARU MUSA YAR'ADUA DRIVE, OWERRI, IMO STATE, NIGERIA., Nigeria | 06/07/2023 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| HK | Department of Health Drug Office | 44222 |
| NG | Registered Drug Product Database | B4-3272 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.